Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

Yvette Florio Lane

Digital Editor
The Lynx Group
Cranbury, NJ
Authored Items
Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
Yvette Florio Lane
Web Exclusives in Breast Cancer, FDA Updates, In the News
Tibsovo Now FDA Approved as First-Line Treatment for AML with IDH1 Mutation
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
FDA Approves Pembrolizumab plus Axitinib for Advanced Renal-Cell Carcinoma
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News, Renal-Cell Carcinoma
April 16, 2019 – FDA Approvals, News & Updates
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News, Lung Cancer
FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer
Yvette Florio Lane
Web Exclusives in Breast Cancer, FDA Updates, In the News
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Yvette Florio Lane
Web Exclusives in Breast Cancer, FDA Updates, In the News
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News, Lung Cancer
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
March 08, 2019 – FDA Approvals, News & Updates
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
February 8, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
February 1, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
Government Shutdown Impacts FDA Drug Approvals
Yvette Florio Lane
Web Exclusives in FDA Updates, In the News
Last modified: June 13, 2019